A
ALKS
Alkermes plc Ordinary Shares
$39.08
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Alkermes plc Ordinary Shares in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
$0.38
P/E
105.3
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.07
Oct 28
Posts
No posts about ALKS yet.
About Alkermes plc Ordinary Shares
Alkermes is an Ireland-based biotechnology company that develops and sells medicines for brain and nervous system conditions, including schizophrenia, bipolar disorder, and alcohol and opioid dependence. It earns money from sales of its own branded drugs and from royalties, which are fees paid by other drug makers that sell products Alkermes helped create.